← Eichor
Study identifier: NCT07556042 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Machine Learning Prediction of Disease Progression in Adolescent Idiopathic Scoliosis

Condition: Adolescence Idiopathic Scoliosis  ·  Sponsor: Istanbul University

PhaseNA
Planned participants30
Who can joinAll sexes, 10 Years to 18 Years
Healthy volunteersNo

About this study

Background and Problem Overview Adolescent Idiopathic Scoliosis (AIS) is a progressive musculoskeletal disorder characterized by a three-dimensional deformation of the spine occurring during adolescence. Diagnosis is typically established with a Cobb angle exceeding 10° and the presence of axial rotation. While the exact etiology remains unknown, leading theories include tissue abnormalities (muscle fibers, bone volume), impaired spinal biomechanics (asymmetric bone growth), and neurological factors (asymmetric cortical thickness, cerebral lateralization, and body schema distortions). The progressive nature of AIS, particularly the high risk of advancement at the onset of puberty, complicates clinical decision-making. Treatment is traditionally divided into three stages: Observation and Exercise: For Cobb angles between 10°-25°. Exercise and Bracing: For Cobb angles between 25°-45°. Surgery: For Cobb angles exceeding 45°. Despite these guidelines, the unpredictable progression of the disease and difficulties in treatment adherence create significant dilemmas. Specifically, for cases on the borderline of surgical indication, clinicians face the challenge of choosing between immediate surgery or conservative monitoring. Currently, there is no definitive method to predict progression, and patients are typically monitored in 6-month intervals. During these intervals, a patient's condition may remain stable or deteriorate significantly. Furthermore, guidelines recommend wear…

This description comes directly from the study's public registry record.

Talk to the study team

Fuat Gökdemir  ·  +90 212 401 26 00  ·  fuatgokdemir95@gmail.com

Ayse Manzak Dursun  ·  +90 212 401 26 00  ·  amanzak@bezmialem.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Bezmialem Vakif UniversityIstanbul, Eyupsultan, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07556042